Cargando…
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study
BACKGROUND: Vaccination against coronavirus disease 2019 (COVID-19) has become an important public health solution. To date, there has been a lack of data on COVID-19 vaccination willingness, vaccine hesitancy, and vaccination coverage in China since the vaccine has become available. METHODS: We des...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043613/ https://www.ncbi.nlm.nih.gov/pubmed/33896661 http://dx.doi.org/10.1016/j.vaccine.2021.04.020 |
_version_ | 1783678338667118592 |
---|---|
author | Wang, Chao Han, Bingfeng Zhao, Tianshuo Liu, Hanyu Liu, Bei Chen, Linyi Xie, Mingzhu Liu, Jiang Zheng, Hui Zhang, Sihui Wang, Yu Huang, Ninghua Du, Juan Liu, Ya-Qiong Lu, Qing-Bin Cui, Fuqiang |
author_facet | Wang, Chao Han, Bingfeng Zhao, Tianshuo Liu, Hanyu Liu, Bei Chen, Linyi Xie, Mingzhu Liu, Jiang Zheng, Hui Zhang, Sihui Wang, Yu Huang, Ninghua Du, Juan Liu, Ya-Qiong Lu, Qing-Bin Cui, Fuqiang |
author_sort | Wang, Chao |
collection | PubMed |
description | BACKGROUND: Vaccination against coronavirus disease 2019 (COVID-19) has become an important public health solution. To date, there has been a lack of data on COVID-19 vaccination willingness, vaccine hesitancy, and vaccination coverage in China since the vaccine has become available. METHODS: We designed and implemented a cross-sectional, population-based online survey to evaluate the willingness, hesitancy, and coverage of the COVID-19 vaccine among the Chinese population. 8742 valid samples were recruited and classified as the vaccine-priority group (n = 3902; 44.6%) and the non-priority group (n = 4840; 55.4%). RESULTS: The proportion of people’s trust in the vaccine, delivery system, and government were 69.0%, 78.0% and 81.3%, respectively. 67.1% of the participants were reportedly willing to accept the COVID-19 vaccination, while 9.0% refused it. 834 (35.5%) reported vaccine hesitancy, including acceptors with doubts (48.8%), refusers (39.4%), and delayers (11.8%). The current coverage was 34.4%, far from reaching the requirements of herd immunity. The predicted rate of COVID-19 vaccination was 64.9%, 68.9% and 81.1% based on the rates of vaccine hesitancy, willingness, and refusal, respectively. CONCLUSIONS: The COVID-19 vaccine rate is far from reaching the requirements of herd immunity, which will require more flexible and comprehensive efforts to improve the population’s confidence and willingness to vaccinate. It should be highlighted that vaccination alone is insufficient to stop the pandemic; further efforts are needed not only to increase vaccination coverage but also to maintain non-specific prevention strategies. |
format | Online Article Text |
id | pubmed-8043613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80436132021-04-14 Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study Wang, Chao Han, Bingfeng Zhao, Tianshuo Liu, Hanyu Liu, Bei Chen, Linyi Xie, Mingzhu Liu, Jiang Zheng, Hui Zhang, Sihui Wang, Yu Huang, Ninghua Du, Juan Liu, Ya-Qiong Lu, Qing-Bin Cui, Fuqiang Vaccine Article BACKGROUND: Vaccination against coronavirus disease 2019 (COVID-19) has become an important public health solution. To date, there has been a lack of data on COVID-19 vaccination willingness, vaccine hesitancy, and vaccination coverage in China since the vaccine has become available. METHODS: We designed and implemented a cross-sectional, population-based online survey to evaluate the willingness, hesitancy, and coverage of the COVID-19 vaccine among the Chinese population. 8742 valid samples were recruited and classified as the vaccine-priority group (n = 3902; 44.6%) and the non-priority group (n = 4840; 55.4%). RESULTS: The proportion of people’s trust in the vaccine, delivery system, and government were 69.0%, 78.0% and 81.3%, respectively. 67.1% of the participants were reportedly willing to accept the COVID-19 vaccination, while 9.0% refused it. 834 (35.5%) reported vaccine hesitancy, including acceptors with doubts (48.8%), refusers (39.4%), and delayers (11.8%). The current coverage was 34.4%, far from reaching the requirements of herd immunity. The predicted rate of COVID-19 vaccination was 64.9%, 68.9% and 81.1% based on the rates of vaccine hesitancy, willingness, and refusal, respectively. CONCLUSIONS: The COVID-19 vaccine rate is far from reaching the requirements of herd immunity, which will require more flexible and comprehensive efforts to improve the population’s confidence and willingness to vaccinate. It should be highlighted that vaccination alone is insufficient to stop the pandemic; further efforts are needed not only to increase vaccination coverage but also to maintain non-specific prevention strategies. Elsevier Ltd. 2021-05-18 2021-04-13 /pmc/articles/PMC8043613/ /pubmed/33896661 http://dx.doi.org/10.1016/j.vaccine.2021.04.020 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Wang, Chao Han, Bingfeng Zhao, Tianshuo Liu, Hanyu Liu, Bei Chen, Linyi Xie, Mingzhu Liu, Jiang Zheng, Hui Zhang, Sihui Wang, Yu Huang, Ninghua Du, Juan Liu, Ya-Qiong Lu, Qing-Bin Cui, Fuqiang Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study |
title | Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study |
title_full | Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study |
title_fullStr | Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study |
title_full_unstemmed | Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study |
title_short | Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study |
title_sort | vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of covid-19 vaccination in china: a national cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043613/ https://www.ncbi.nlm.nih.gov/pubmed/33896661 http://dx.doi.org/10.1016/j.vaccine.2021.04.020 |
work_keys_str_mv | AT wangchao vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT hanbingfeng vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT zhaotianshuo vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT liuhanyu vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT liubei vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT chenlinyi vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT xiemingzhu vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT liujiang vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT zhenghui vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT zhangsihui vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT wangyu vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT huangninghua vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT dujuan vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT liuyaqiong vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT luqingbin vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy AT cuifuqiang vaccinationwillingnessvaccinehesitancyandestimatedcoverageatthefirstroundofcovid19vaccinationinchinaanationalcrosssectionalstudy |